July 10, 2025

HHS Scraps Preventive Care Panel Meeting

HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.

Conexiant

July 10, 2025

Apheresis Shows Promise for Removing Microplastics From Human Blood

Extracorporeal therapeutic apheresis demonstrated the ability to remove microplastic-like particles from human blood in patients with myalgic encephalomyelitis/chronic fatigue syndrome, according to a study published in Brain Medicine.

Conexiant

July 10, 2025

1 in 4 US Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

July 09, 2025

Medical Oddities: Mondays May Mess With Hormones

Monday cortisol, THC slip-ups, rewiring retinas, tea-buffed muscles, and psyche gyms are what’s the buzz this week!

Conexiant

July 09, 2025

ESC: Vaccines May Prevent Major Heart Events

A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.

Conexiant

July 09, 2025

E. coli Upcycle Turns Plastic to Pills

Scientists engineered E. coli to perform a synthetic chemical reaction that enables the conversion of plastic waste into the common drug paracetamol using a non-toxic, phosphate-driven process inside living cells.

Conexiant

July 08, 2025

Next-Gen Flu Vaccines Show Global Value

Researchers project that next-generation influenza vaccines could prevent up to 3 billion infections and be cost-effective in many countries with appropriate pricing strategies.

Conexiant

July 08, 2025

Breathing More Easily, With Biomarkers

When traditional diagnostics fall short, biomarker testing offers respiratory relief in resource-limited settings

The Pathologist

July 07, 2025

FDA Approves First Oral Hereditary Angioedema Treatment

FDA approves Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema, shown in trials to provide faster symptom relief and eliminate the need for injection.

Conexiant